Heat Shock Protein 90 c-Terminal Inhibitors in Cancer Treatment
<p>Heat shock protein 90 (Hsp90) is 90 kDa highly conserved dimeric chaperone protein in prokaryotic and eukaryotic cells and it is localized in different parts of the cell. Hsp90AA1 (inducible) and Hsp90AB1 (constitutive) are available in the cytosol; Grp94 and TRAP1 exist in endoplasmic reti...
Guardat en:
Autor principal: | Yusuf Tutar (Autor) |
---|---|
Format: | Llibre |
Publicat: |
International Journal of Pharmaceutical Sciences and Developmental Research - Peertechz Publications,
2015-05-16.
|
Matèries: | |
Accés en línia: | Connect to this object online. |
Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
Ítems similars
-
Discovery and development of natural heat shock protein 90 inhibitors in cancer treatment
per: Yong Li, et al.
Publicat: (2012) -
Heat Shock Protein 90 (Hsp90) Expression and Breast Cancer
per: Christos A. Papadimitriou, et al.
Publicat: (2012) -
Heat Shock Protein 90 and Role of Its Chemical Inhibitors in Treatment of Hematologic Malignancies
per: Haojian Zhang, et al.
Publicat: (2012) -
Effects of Heat Shock Protein 90 Inhibition In the Lungs
per: Mohammad A. Uddin, et al.
Publicat: (2020) -
Therapeutic Potential of Heat Shock Protein 90 Inhibitors, Geldanamycin, and Analog Compounds in Precision Cancer Therapy
per: Atta Mohammed Alzebari, et al.
Publicat: (2023)